Try our beta test site
14 studies found for:    Northwestern AND Cystic fibrosis
Show Display Options
Rank Status Study
1 Not yet recruiting Urinary and Anorectal Functional Disorders and Their Impact on CF Adults (PerineoMucoRMO)
Condition: Cystic Fibrosis
Intervention:
2 Completed Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Xylitol;   Drug: Xylo-pentane-1,2,3,4 5-pentol
3 Recruiting Genetic Modifiers of Cystic Fibrosis Related Diabetes
Condition: Cystic Fibrosis Related Diabetes
Intervention:
4 Recruiting Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Interventions: Drug: QR-010;   Drug: Placebo
5 Completed
Has Results
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Condition: Cystic Fibrosis
Interventions: Drug: N6022;   Drug: Normal saline
6 Completed Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
Condition: Cystic Fibrosis
Intervention: Drug: N91115
7 Completed Long Term Administration of Inhaled Mannitol in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: inhaled mannitol;   Drug: Placebo comparator
8 Completed Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Interventions: Drug: Vancomycin inhalation powder;   Drug: Placebo inhalation powder
9 Completed
Has Results
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Condition: Cystic Fibrosis
Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID);   Drug: Placebo two times a day (BID)/three times a day (TID)
10 Completed
Has Results
International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Condition: Cystic Fibrosis
Interventions: Drug: AZLI 75 mg three times a day (TID);   Drug: Placebo three times a day (TID)
11 Completed Infant Study of Inhaled Saline in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: 7% Hypertonic Saline (HS);   Drug: 0.9% Isotonic Saline (IS)
12 Recruiting A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)
Condition: Cystic Fibrosis
Interventions: Drug: Gallium nitrate;   Drug: Normal Saline
13 Completed Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation
Condition: Cystic Fibrosis
Interventions: Drug: Cavosonstat;   Drug: Placebo
14 Recruiting Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With CF
Condition: Cystic Fibrosis
Interventions: Drug: azithromycin;   Drug: placebo (for azithromycin);   Drug: inhaled tobramycin

Study has passed its completion date and status has not been verified in more than two years.